| A: long GnRH agonist | B: ultralong GnRH agonist | C: GnRH antagonist |  |
---|---|---|---|---|
Characteristics | N = 362 | N = 369 | N = 523 | P value |
Age (years) | 29.4 ± 3.7 | 29.2 ± 3.5 | 29.1 ± 3.5 | 0.547 |
BMI (kg/m2) | 25.2 ± 25.6 | 25.8 ± 33.3 | 24.1 ± 4.0 | 0.525 |
Infertility duration (years) | 4.3 ± 2.9 | 4.0 ± 2.4 | 4.1 ± 2.6 | 0.468 |
AFC | 18.1 ± 6.2 | 25.6 ± 10.8 | 24.5 ± 9.5 | <0.001a |
Basal FSH (IU/L) | 6.2 ± 2.5 | 6.5 ± 1.8 | 6.5 ± 2.8 | 0.097 |
Basal LH (IU/L) | 6.0 ± 4.6 | 7.7 ± 6.3 | 6.7 ± 4.3 | <0.001b |
Basal estrogen (pg/mL) | 53.1 ± 124.1 | 48.0 ± 27.5 | 65.7 ± 203.4 | 0.184 |
Fasting serum glucose (mmol/L) | 5.0 ± 0.5 | 5.1 ± 0.5 | 5.2 ± 0.8 | <0.001c |
Follicles≥14 mm* | 14.1 ± 7.8 | 17.1 ± 6.9 | 16.6 ± 7.3 | 0.176 |
Days of stimulation | 10.3 ± 2.3 | 12.2 ± 3.2 | 10.5 ± 3.3 | <0.001d |
Gn dosage (IU/L) | 2456.1 ± 946.1 | 2604.1 ± 1233.9 | 2322.9 ± 1136.9 | 0.001e |
Serum estrogen (pg/mL) * | 4854.8 ± 2710.9 | 3477.0 ± 2266.0 | 4691.8 ± 3012.0 | <0.001f |
Serum Progesterone (ng/mL) * | 0.9 ± 0.4 | 0.9 ± 0.7 | 1.1 ± 0.7 | <0.001g |
Serum P/E2 ratio * | 0.2 ± 0.2 | 0.4 ± 1.0 | 0.3 ± 0.4 | 0.036h |
Endometrial thickness on ET day * (cm) | 1.0 ± 0.2 | 1.2 ± 0.3 | 1.0 ± 0.2 | <0.001i |
Oocytes retrieved | 15.4 ± 7.0 | 15.7 ± 7.1 | 15.8 ± 8.0 | 0.721 |
2PN oocytes rate (%) | 57.6% (3214/5581) | 54.5% (3158/5792) | 56.7% (4696/8278) | 0.003j |
Cleavage rate of 2PN oocytes (%) | 98.1% (3154/3214) | 97.2% (3069/3158) | 97.9% (4599/4696) | 0.023k |
High-quality embryo rate (%) | 66.2% (2128/3214) | 63.4% (2001/3158) | 68.1% (3199/4696) | <0.001l |
Number of embryo transfer cycle | 214 | 204 | 243 | Â |
Cycle cancellation rate (%) | 40.9%(148/362) | 44.7%(165/369) | 53.5%(280/523) | 0.001m |
Rate of cancelled cycles due to inadequate endometrial thickness (%) | 3.4%(5/148) | 5.5%(9/165) | 9.6%(27/280) | 0.036n |
Rate of cancelled cycles due to OHSS prevention (%) | 48.0%(71/148) | 74.5%(123/165) | 56.4%(158/280) | <0.001o |
Rate of cancelled cycles due to high P level (%)* | 4.1%(6/148) | 1.8%(3/165) | 3.9%(11/280) | 0.427 |
Rate of cancelled cycles due to no embryos obtained (%) | 4.1%(6/148) | 4.2%(7/165) | 4.3%(12/280) | 0.471 |
Rate of cancelled cycles due to no oocytes retrieved (%) | 0.7%(1/148) | 0.6%(1/165) | 0.0%(0/280) | 0.405 |
Rate of cancelled cycles due to other reasons (%) | 39.9%(59/148) | 13.3%(22/165) | 25.7%(72/280) | <0.001p |
Freeze-all cycles rate (%) | 39.0%(141/362) | 42.5%(157/369) | 51.2%(268/523) | 0.001q |
Implantation rate (%) | 31.6% (132/418) | 45.0% (175/389) | 22.3% (107/479) | <0.001r |
HCG+ rate (%) | 56.5% (121/214) | 71.6% (146/204) | 52.3% (127/243) | <0.001s |
Clinical pregnancy rate (%) | 42.5% (91/214) | 62.7% (128/204) | 35.4% (86/243) | <0.001t |
Ectopic pregnancy rate (%) | 1.4% (3/214) | 1.0% (2/204) | 2.9% (7/243) | 0.279 |
Early miscarriage rate (%) | 3.3% (7/214) | 4.4% (9/204) | 3.3% (8/243) | 0.773 |
Live birth rate (%) | 10.7%(23/214) | 25.5%(52/204) | 9.8%(24/243) | <0.001u |